0
Iovance Biotherapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0.16
FY24:
70.8
FY25:
90.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−343
FY22:
−399
FY23:
−461
FY24:
−395
FY25:
−403
(positive)
Change from FY21 to FY22
millions USD
FY21:
−329
FY22:
−378
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−342
FY22:
−396
FY23:
−448
FY24:
−375
FY25:
−393
(positive)
Change from FY21 to FY25
millions USD
FY21:
−342
FY22:
−396
FY23:
−444
FY24:
−372
FY25:
−391
All amounts in millions USD